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Background/Aims: Hypoxia-inducible factor-1α (HIF-1α) is a central transcriptional factor involved in the cellular responses 
related to various aspects of cancer biology, including proliferation, survival, and angiogenesis, and the metabolism of the 
extracellular matrix in hypoxia. This study evaluated whether adenovirus-mediated small hairpin RNA (shRNA) against HIF-1α 
(shHIF-1α) inhibits cell proliferation and angiogenesis in hepatocellular carcinoma (HCC) cell lines. Methods: Knockdown of 
HIF-1α expression was constructed by adenovirus-mediated RNA interference tools, and HCC cell lines infected with shHIF-1α 
coding virus were cultured under a hypoxia condition (1% O2) for 24 hours. Following infection, the expression levels of HIF-1α, 
angiogenesis factors, and matrix metalloproteinase (MMP) were examined using Western blotting. Cell proliferation and 
angiogenesis were measured by a cell proliferation assay (MTT assay) and an angiogenesis-related assay (invasion and 
tube-formation assay), respectively. Results: Adenovirus mediated inhibition of HIF-1α induced suppression of tumor growth in 
HCC cell lines. It also down-regulated the expression of angiogenesis factor and MMP proteins. Angiogenesis as well as mobility 
of vascular cells to tumor was suppressed by adenovirus-mediated shHIF-1α-infected groups in human umbilical vein endothelial 
cells (HUVECs). Conclusions: These data suggest that adenovirus-mediated inhibition of HIF-1α inhibits the invasion, tube 
formation, and cell growth in HUVECs and HCC cells. (Korean J Hepatol 2010;16:280-287)
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INTRODUCTION
Hepatocellular carcinoma (HCC) is the 5th most common ma-
lignant tumor and approximately 500,000 new cases are reported 
every year. Furthermore, the mortality rate of primary hepatic 
malignancies ranks 3rd place on the tumor related mortality rate 
scale.1 It is one of the most well-known hypervascular tumors in 
which lots of blood vessels are formed as the tumor grows.2,3
Angiogenesis is a major in vivo phenomenon which generates 
capillaries from existing blood vessels.4,5 Also, this phenomenon 
can appear when a wound occurs in a particular organ or tissue. 
As well, angiogenesis can also play an important role in growth 
and metastasis of malignant tumors.4,6 It is known that the 
generation of blood vessels is regulated by various growth 
factors.5-7
A cell overcomes the hypoxic state by activating the 
transcription of genes related to glycogen degradation, blood cell 
generation, blood vessels formation, infiltration, etc.8-10 The 
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Replication-incompetent Ad ΔE3
ΨITR ITRIX     Adenoviral genomeLacZU6 PolA Ad-ΔE1
ΨITR ITRIX     Adenoviral genomeshHif1aU6 PolA Ad-ΔE1-shHif-1a
Forward: 5’-gatccccATCCAGAGTCACTGGAACTttcaagaga
AGTTCCAGTGACTCTGGATtttttggaaa-3
Reverse: 3’-gggTAGGTCTCAGTGACCTTGAaagttctct
TCAAGGTCACTGAGACCTAaaaaaccttttcga-5’
Figure 1. Construction of adenovirus mediated small hairpin 
hypoxia inducible factor-1α (HIF-1α). Schematic representation 
of the genomic structure of the adenoviral vectors (Ad) used. 
Ad-shHIF-1α, adenoviral-mediated small hairpin HIF-1α: 
Ad-ΔE1, adenoviral-mediated deletion of the E1 site.
hypoxia inducible factor-1α (HIF-1α) is known as an important 
transcription factor in this state. HIF-1α is activated when it is 
bound to HIF-1β (ARNT), and the activated factor further 
activates target genes that are related to angiogenic effect, tumor 
growth, apoptosis, etc, by activating the hypoxia responsive 
element (HRE) sequence.11-13 The HIF-1α maintains a low 
concentration under normal oxygen levels due to the von 
hippel-lindau (vhl)-ubiquitin dependent protein degradation 
process. In the hypoxic level, the vhl-ubiquitin dependent protein 
degradation process is hindered so target genes are activated due 
to the increased concentration of HIF-1α and increased binding 
of HIF-1α to HRE. 14,15 During the growth process of cancer cells, 
localized hypoxia is caused due to the excessive division of 
cancer cells and HIF-1α stimulates angiogenesis and plays a role 
in the metastasis of cancer cells.4,14
In this study, an adenovirus mediated small hairpin HIF-1α 
(shHIF-1α) which efficiently inhibits HIF-1α expression was 
constructed, and also the HIF-1α inhibition effect on the 
proliferation of HCC cell lines and angiogenesis was studied by 
inducing infection in HCC cell lines (HepG2, Huh7).
MATERIALS AND METHODS
1. Construction of an adenovirus mediated
shHIF-1α for the HIF-1α gene
The 19 nucleic acid sequence of small hairpin RNA (shRNA) 
which targets the HIF-1α gene sequence was constructed by the 
method reported in previous studies.14,15,20 Also, the shRNA 
inserted in the vector of adenovirus was constructed by inserting 
the loop sequence which forms a small hairpin structure in the 
middle of the vector.16,17 The E1 site, which is responsible for the 
proliferation of adenovirus, was removed by BamHΙ and Hind Ⅲ 
(Biolabs, Ipswich, MA, USA) and the shRNA bound to 
pSilencer-2.1-hygro-U6 vector was inserted into the pSP72-E3 
Ad vector. Essentially, a replication-incompetent adenovirus 
mediated shHIF-1a with a U6 promoter and specific shHIF-1a 
sequence was created. Before infecting the cells with the 
constructed virus, quantification with 1×1012 vp/ml through 
DNA titering. Through the above procedures, replication- 
incompetent adenovirus mediated shHIF-1α was produced by 
inserting the shRNA (Fig. 1).
2. Infection of adenovirus mediated shHIF-1α
After cultivating certain numbers of HCC cell lines (HepG2, 
Huh7) in the culture medium, the medium was changed to a 5% 
serum medium (Dulbecco Modified Eagle’s Mediaum, GIBCO, 
Invitrogen, CA, USA) before infecting it with the virus. The cell 
lines were then infected with the virus at desired MOI (multiplicity 
of infection, the number of infected virus per one cell) by simply 
adding in the media. It was cultivated for a 24 hour period in a 
normoxia condition (normoxia condition-21% O2), and after 
changing the 5% serum DMEM (non-antibiotics) medium it 
was cultured for a 24 hour period in a hypoxia condition 
(hypoxia condition-1% O2, 5% CO2, 94% N2). The change of 
status was observed by optical microscope.
3. Immunoblot assay
The Western blot was performed in order to determine the 
effect of HIF-1α expression inhibition on the protein expression 
related to proliferation of HCC cell lines and angiogenesis. The 
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adenoviral-mediated shIHF-1α (Ad-shHIF-1α) infected HCC 
cell lines were incubated in a hypoxia condition during a 24-hour 
period. Protein was extracted after cell lysis [NP-40 Lysis buffer: 
5M NaCl-30 mL, 10% NP-40-100 mL, 50 mL 1M Tris (pH8.0) 
per liter]. All cell lysis took place on ice for an hour using the 
lysis buffer. Also, the proteins were separated according to their 
molecular weight by SDS-PAGE (Sodium Dodecyl Sulfate- 
Polyacrylamide Gel Electrophoresis). The separated proteins on 
the gel were transferred to the PVDF membrane (GE healthcare, 
Amersham, Buckinghamshire, UK), and then bound with mouse 
monoclonal antibodies to HIF-1α (1:500 dilution, BD bioscience, 
CA, USA), vascular endothelial growth factor (VEGF, 1:500 
dilution, Millipore, CA, USA), matrix metalloproteinase-2 
(MMP-2, 1:500 dilution, Invitrogen, CA, USA), and β-actin 
(1:3,000 dilution, Santacruz, CA, USA). A secondary goat anti 
mouse antibody tagged Horseradish peroxidase (1:5,000 
dilution, Santacruz, CA, USA) was bound to the primary antibody 
and developed by enhanced chemo-illumination (Perkinelimer, 
Boston, MA, USA). The quantification of each protein expression 
was comparatively analyzed.
4. Cell growth assay
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT: Amresco, OH, USA) was treated to cells and the 
growth rate of the cell was measured by observing the increased 
rate of cell number. After seeding in a 96 well plate with 5×103 
cell/well it was incubated at 37℃ during a 24-hour period. It was 
infected with adenovirus (Ad-shHIF-1α, Ad-ΔE1) after transferring 
it to a serum free media. After cultivation in a normoxia 
condition (normoxia condition-21% O2) for a 24-hour period, it 
was transferred to a Serum 10% medium and a hypoxia induction 
(hypoxia induction-1% O2) was given. The stimulated well was 
cell dyed with MTT and cultivated in 37℃ for a 3~4 hour period 
for efficient cell dyeing. After removing the MTT mixed media, 
it was treated with DMSO (Dimethylsulfoxide, Sigma-Aldrich, 
MO, USA) 150 µL for 5 minutes at room temperature and the 
proliferation was measured by spectrophotometry (Molecular 
Devices) 595 nm.
5. Production of condition media
After cultivating the adenovirus infected HCC cell lines group 
and adenovirus uninfected HCC cell lines group in a hypoxia 
condition during a 24-hour period, 500 μL culture media was 
injected in the amicon (Millipore, Billerica, MA, USA), and it 
was repeatedly concentrated at 4℃, 10,000 rpm during 30 minutes. 
It was washed by centrifugation with sterile distilled water until 
the amicon membrane was transparent. After injecting 3rd sterile 
distilled water 100 μL, the plate of the amicon membrane was 
conversed and the 100 μL concentrated culture media was 
collected after centrifugation. The collected culture media was 
used in various experiments such as invasion, tube formation, 
migration assay, etc.
6. Angiogenesis assay
The migration assay which detects the mobility of the cell, 
invasion assay which confirms the cell invasion capacity, and the 
tube formation assay which measures the tube formation of 
vascular cells were done by using the HUVEC (human umbilical 
vein endothelial cell).2.3.17 Each experimental result was observed 
by optical microscope (×40).
7. Statistical analysis
Each experiment was expressed in average±standard deviation, 
and frequency (%). Statistical analysis was done by independent- 
t-test SPSS 12.0 (SPSS Inc, Chicago, USA). Statistically 
significant level between the control group and experiment 
group was set at P value<0.05.
RESULTS
1. Construction of adenovirus mediated shHIF-1α 
and inhibition of tumor growth
An in vivo replication-incompetent Ad-shHIF-1α which 
efficiently inhibits the HIF-1α expression was constructed. The 
quantitative value for the in vivo infection was calculated by the 
MOI and the growth inhibition effect was confirmed through 
MTT assay by the treatment with increasing MOI of the virus. 
After 72 hours of treatment, the increased growth inhibitions of 
HCC cell lines were observed as the MOI increases (Fig. 2A). In 
the HepG2 cell line, a 40.3±3.4% (0.79±0.05 p-value:0.05) 
proliferation inhibition effect was seen in 100 MOI and 
45.0±7.6% was seen in 200 MOI. In the Huh7 cell line, 
44.7±14.4% (0.87±0.35, p-value:0.05) proliferation inhibition 
effect was seen in 100 MOI and 41.6±0.7% (0.62±0.30, p-value: 
0.05) was seen in 200 MOI. But at infections higher than 200 
MOI, cytotoxicity was confirmed through the viability assay in 
both cell lines (data not shown). Also the time-dependency of the 
growth inhibition rate of HCC cell lines was confirmed (Fig. 2B). 
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Figure 3. Expression level of angiogenic factor by suppressing 
HIF-1α in Huh7 cells. (A) The expression of HIF-1α decreased in an 
MOI-dependent manner under the hypoxia condition. (B) The 
hypoxic induction of angiogenesis factors and MMP was partially 
blocked in the HIF-1α-blocked HCC cell line (*P<0.05 versus Ad-Δ
E1 treatment). 
HIF-1α, hypoxia inducible factor-1α; MOI, multiplicity of 
infection; MMP, matrix metalloproteinase.
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Figure 2. Inhibition of tumor cell growth by shHIF-1α. HIF-1α-knockdown HCC cell lines were incubated under a hypoxia condition 
(0.1% O2). (A) After 72 hours, tumor cell growth (HepG2 and Huh7 cells) was inhibited by MOI-dependent Ad-shHIF-1α. (B) The daily 
growth was greater in the non-infected group than in the adenovirus-mediated HIF-1α-knockdown group (*P<0.05 versus Ad-ΔE1 
treatment).  
shHIF-1α, small hairpin hypoxia inducible factor-1α; HCC, hepatocellular carcinoma; MOI, multiplicity of infection; Ad-shHIF-1α, 
adenoviral-mediated small hairpin HIF-1α: Ad-ΔE1, adenoviral-mediated deletion of the E1 site.
After Ad-shHIF-1α infection, the growth rates of the two 
infected HCC cell lines were inhibited compared to the control 
groups. From the experimental data, it was ascertained that 
adenoviral vector expressing shHIF-1a transducted in hypoxic 
conditions induced an inhibition effect of the cell proliferation.
2. Knockdown of HIF-1α affects expression of 
variable proteins
The amounts of expressed proteins in uninfected Huh7 and 
Huh7 infected with Ad-shHIF-1a and Ad-ΔE1 independently 
were measured. The MOI dependent knockdown of HIF-1α by 
shHIF-1α was confirmed by Western blot (Fig. 3A). According 
to the comparative analysis of the density of HIF-1α expression 
band, the expression decreased up to 50% at 100 MOI. The 
expression rate of VEGF and MMP-2 were measured in order to 
observe the effect of the inhibition of HIF-1α on factors involved 
A B
A
B
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Figure 4. Effects of adenovirus-mediated shHIF-1α expression on migration. The conditioned medium collected from Ad-Δ
E1-transduced Huh7 cells induced an increase in motility. However, the conditioned medium from Ad-shHIF-1α-transduced 
cells inhibited migration on HUVECs (bar length indicates the extension of HUVEC motility). 
shHIF-1α, small hairpin hypoxia inducible factor-1α; Ad-ΔE1, adenoviral-mediated deletion of the E1 site; Ad-shHIF-1α, 
adenoviral-mediated small hairpin HIF-1α: HUVEC, human umbilical vein endothelial cells.
in angiogenesis. According to the observation, the VEGF protein 
expression rate decreased approximately 68% compared to the 
Ad-ΔE1 control group, and the pre-transition related MMP-2 
protein expression rate decreased approximately 57% (Fig. 3B). 
According to the experiment results, it was confirmed that the 
expressions of VEGF and MMP-2 were down-regulated by the 
knockdowon of HIF-1α in a hypoxia condition. 
3. Inhibition of migration by adenovirus-mediated 
shHIF-1α
After a 24-hour period, migration of HUVEC in the overall 
well occurred in the non-treated control group and Ad-ΔE1 virus 
treated group after the treatment with condition media. However, 
a condition media from the sample treated with Ad-shHIF-1α at 
50 MOI induced a decrease of migration by 50% compared to the 
initial migration as seen by a decrease of approximately 50% of 
the bar representing 0h compared the 24h bar, and at the 100 
MOI almost no migration of HUVEC was observed (Fig. 4). The 
data strongly suggest that the inhibition of HIF-1α expression 
further inhibits the mobility of tumor vascular cells from the 
blood vessel to the tumor.
4. Inhibition of angiogenesis by adenovirus 
mediated shHIF-1α
Based on the Western blot result where the expression of 
VEGF and MMP-2 decreased, the cell infiltration induced by the 
growth factors expressed in the HCC cells and the tube formation 
was measured using the special media (condition media) 
obtained from the HCC cell lines. Using the hematoxylin-eosin 
dye, it was confirmed that in the untreated group and the Ad-ΔE1 
virus infected group, most of the vascular cells distributed in the 
gelatin region through the membrane. In the group treated with 
condition media of 50 MOI, cell infiltration was partially 
inhibited, and at 100 MOI approximately 60% of cell infiltration 
inhibition was observed (Fig. 5A). In the untreated group and the 
Ad-ΔE1 virus infected group, uniform tube formation of the 
vascular cell occurred and the tube was thick and clear. But in the 
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Figure 5. Effects of adenovirus-mediated shHIF-1α expression on invasion and tube formation. (A) The conditioned medium collected from 
Ad-ΔE1-transduced Huh7 cells induced invasion, whereas that from Ad-shHIF-1α-transduced Huh7 cells inhibited MOI-dependent inroads. 
(B) The conditioned medium collected from Ad-ΔE1-transduced Huh7 cells induced the formation of an extensive network of organized, 
elongated tube-like structures that resembled capillaries. However, the conditioned medium from Ad-shHIF-1α-transduced cells inhibited 
tube-forming structures, with the plate instead becoming filled with an incomplete network of a capillary-like structure on HUVECs (arrows). 
shHIF-1α, small hairpin hypoxia inducible factor-1α; Ad-ΔE1, adenoviral-mediated deletion of the E1 site; MOI, multiplicity of infection; 
HUVEC, human umbilical vein endothelial cells.
50 MOI treated group, the diameter of some tubes decreased and 
in the 100 MOI treated group most of the tubes became thin and 
also broken and therefore did not form good tube structure (Fig. 
5B). This experiment confirmed that the inhibition of HIF-1α 
expression induces the inhibition of angiogenic effect.
DISCUSSION
Excessive localized hypoxia during the division of cancer 
cells is one of the singularities in the growth phase of the cancer 
cell.8 Severe cell damage can occur if the hypoxic condition is 
maintained and cell growth is inhibited due to lack of oxygen and 
nutrition.8.10 Also, the HIF-1α which receives the hypoxic signal 
becomes accumulated in the cell and if it is transferred to the 
nucleus, it induces the expression of angiogenesis-related genes 
and the expression of genes related to the metastasis of cancer 
cells.11 The series of tumor growth programs suppresses cell 
damage by supplying oxygen and nutrition to the tumor and 
induces tumor growth. The inhibition of HIF-1α expression 
blocks the HIF-1α function as a transcription factor, so as a 
result, the angiogenic effect, tumor growth, metastasis effect 
which are manipulated by the HIF-1α are all inhibited step by 
step.19,20 
The RNAi is an experimental method which hinders the in 
vivo translation of mRNA in order to control the expression rate 
of a certain gene. In the previous papers, it was reported that the 
in vivo and in vitro RNAi tool experiment has an effect on 
survival and proliferation of tumor,25,30 and the possibility of 
application as cancer treatment is suggested.25 But there has to be 
various modifications such as sustainability, safety, and efficiency 
in order for the RNAi to be applied in clinical treatment. The 
transfer into the cell is known to be the greatest problem and by 
using the virus vector, an efficient transfer of RNAi into the cell 
can be possible. Actually, efficient transfer of RNAi into the cell 
by the virus vectors such as, retrovirus and adenovirus have 
already been confirmed.26,27 Also, one of the weak points of 
siRNA is that the in vivo duration time is short, 28 but recently it is 
reported that the short duration time can be solved by using the 
virus vector.28,29 The adenovirus mediated small hairpin HIF-1α 
was manufactured based methods delineated in previous studies. 
shHIF-1α is transcribed into ssRNA similar to the hairpin loop of 
pre-miRNA which is regulated by RNA polymerase III and 
A B
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transferred to the cytoplasm by Exportin-5 to knock down the 
function of the target gene following a series of processes, 
playing the same role as siRNA.17,25 When the HCC cell lines are 
treated MOI dependently with adenovirus mediated shHIF-1α, 
the numbers of in vivo activating shHIF-1a increases as the MOI 
increases, so it was concluded that it inhibits the expression of 
HIF-1α and cell proliferation. Also by measuring the inhibition 
rate as time passed by, the inhibition rate increased compared to 
the control group. It was reported that the inhibition effect 
decreases after 48 hours in a previous study which conducted an 
experiment using siRNA,28,30 and the short duration time had 
been one of its defects, but in this study the inhibition effect on 
the virus was maintained even after 5 days. In this study, the 
inhibition effect induced by the virus remained even after 5 days. 
This study was carried out for a total of 7 days and there was no 
significant change in experimental data on the 7th day compared 
to the 5th. After the 5th day, the minimum surface area needed for 
cell proliferation was insufficient and further study in a larger 
culture area is needed (data not shown). By confirming the 
expression change in VEGF and MMP-2 on a molecular level, 
the HIF-1α of the adenovirus mediated shHIF-1α treated group 
was inhibited dependently of MOI and as a result, the expression 
of VEGF and MMP-2 were also partially inhibited. It was 
confirmed that the long-term inhibition of the proliferation of 
cancer cells and angiogenesis activity regulated by the HIF-1α is 
possible in a hypoxic condition by inhibiting the expression of 
HIF-1α using the adenovirus. Also during the in vitro 
experiment, the efficient transfer of shRNA which plays a similar 
role in siRNA is possible by using the virus instead of other 
transfection agents. According to this experiment, it was 
confirmed that the HIF-1α expression affects the proliferation, 
angiogenesis, and metastasis of cancer cells and the inhibition of 
the expression of virus meditated HIF-1α inhibits the continuous 
proliferation of cancer cells. It also inhibits angiogenesis for a 
long-term duration.
Based on the data on a molecular level, the shHIF-1α inhibited 
the angiogenesis and proliferation of the blood vessel during the 
angiogenesis and cell mobility experiment, as expected. The 
vascular endothelial cell migration plays an important role in 
angiogenesis. The proteins expressed by the tumor such as 
VEGF and MMP-2 plays an important role in transferring the 
endothelial cells to the tumor. The transfer of endothelial cells to 
the tumor can be inhibited by inhibiting the proteins expressed by 
the tumor. However, it is difficult to describe the effect of 
angiogenesis in detail by just the in vitro experiment due to 
HIF-1a expression inhibition on the tumor. Animal experiments 
that show the regulation of tissue growth factor expression in 
hepatocellular carcinoma by HIF-1α expression and angiogenesis 
has also been conducted. In addition, angiogenesis is regulated 
by more than one factor and is a combination reaction inside cells 
or tissues, so additional research on factors other than HIF-1α is 
required.23,24
The regulation of HIF-1α expression is an important 
mechanism in tumor growth and angiogenesis. The hypoxia 
induced by the tumor growth is an important key to the 
expression of HIF-1α and the induced HIF-1α in a hypoxia state 
becomes activated as a transcription factor and regulates the 
growth factors related to tumor growth and angiogenesis. It also 
regulates the control factors which regulates the growth factors. 
For example, if the HIF-1a expression is inhibited, the expression 
of sub-genes such as, VEGF and MMP-2 are also repressed. 
Taken together, it can be confirmed that the inhibition of 
HIF-1α expression ultimately represses the growth of tumor or 
transition, and this concept is key in developing an efficient 
treatment model which does not damage normal cells. 
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